Literature DB >> 7288595

Pharmacokinetics of digoxin in the turkey and comparison with other species.

E Park, S Einzig, N A Staley, G R Noren.   

Abstract

Digoxin was administered by bolus intravenous injection to seven broad-breasted white turkey poults at doses of 0.1, 0.15, or 0.2 mg/kg. Plasma digoxin concentrations were measured by a 125I radioimmunoassay at selected times over the subsequent 24 hr. The data were fitted to a two compartment open pharmacokinetic model. Overall mean values for kinetic variables were: distribution halflife, 38.96 min; elimination halflife, 11.03 hr; volume of distribution in the central compartment, 1.54 liters/kg; total body clearance, 5.81 ml/min/kg. Different doses did not appear to have a significant effect on the identifiable pharmacokinetic variables, suggesting that digoxin disposition is dose independent in the turkey. The results obtained in turkeys were compared with data reported for rats, cats, dogs, and humans. The value for total body clearance of digoxin in the turkey was similar to values found in man, dogs, and cats but considerably less than values reported for rats. The value for elimination halflife in turkeys was somewhat less than values reported for infants and dogs; however, it was considerably different than values reported for rats and cats.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7288595     DOI: 10.1007/BF01059271

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  19 in total

1.  Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses.

Authors:  J R Koup; D J Greenblatt; W J Jusko; T W Smith; J Koch-Weser
Journal:  J Pharmacokinet Biopharm       Date:  1975-06

2.  Biochemical basis for the low sensitivity of the rat heart to digitalis.

Authors:  T Akera; S Yamamoto; J Chubb; R McNish; T M Brody
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-08       Impact factor: 3.000

3.  Employment of the embryonic duck heart for the detection of minute amounts of a digitalis glycoside (lanatoside C).

Authors:  M FRIEDMAN; R BINE
Journal:  Proc Soc Exp Biol Med       Date:  1947-02

4.  Pharmacokinetics of digoxin in the rat.

Authors:  L I Harrison; M Gibaldi
Journal:  Drug Metab Dispos       Date:  1976 Jan-Feb       Impact factor: 3.922

5.  Dose-independent pharmacokinetics of digoxin in humans.

Authors:  H R Ochs; D J Greenblatt; G Bodem; J S Harmatz
Journal:  Am Heart J       Date:  1978-10       Impact factor: 4.749

6.  Pharmacokinetics of digoxin: comparison of a two- and a three-compartment model in man.

Authors:  W G Kramer; R P Lewis; T C Cobb; W F Forester; J A Visconti; L A Wanke; H G Boxenbaum; R H Reuning
Journal:  J Pharmacokinet Biopharm       Date:  1974-08

7.  The specificity of the digoxin radioimmunoassay procedure.

Authors:  R G Stoll; M S Christensen; E Sakmar; J G Wagner
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1972-11

8.  Experimental electrophysiological studies on avian hearts.

Authors:  E N Moore
Journal:  Ann N Y Acad Sci       Date:  1965-09-08       Impact factor: 5.691

Review 9.  Clinical pharmacokinetics of digoxin.

Authors:  E Iisalo
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

10.  Pharmacokinetics of digoxin in the cat and comparisons with man and the dog.

Authors:  D J Weidler; N S Jallad; H S Movahhed; E Sakmar; J G Wagner
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1978-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.